Suppression of cancer cell growth using nanoparticles containing two different amino acid-degrading enzymes
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (24)
Show source-provided references
1. Duval K, Grover H, Han L-H, Mou Y, Pegoraro AF, Fredberg J, Chen Z (2017) Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda) 32:266–277. https://doi.org/10.1152/physiol.00036.201610.1152/physiol.00036.2016 ↗
2. Kumari P, Jain S, Ghosh B, Zorin V, Biswas S (2017) Polylactide-based block copolymeric micelles loaded with chlorin e6 for photodynamic therapy: in vitro evaluation in monolayer and 3D spheroid models. Mol Pharm 14:3789–3800. https://doi.org/10.1021/acs.molpharmaceut.7b0054810.1021/acs.molpharmaceut.7b00548 ↗
3. Bhatt H, Kiran Rompicharla SVK, Ghosh B, Biswas S (2019) α-Tocopherol succinate-anchored pegylated poly(amidoamine) dendrimer for the delivery of paclitaxel: assessment of in vitro and in vivo therapeutic efficacy. Mol Pharm 16:1541–1554. https://doi.org/10.1021/acs.molpharmaceut.8b0123210.1021/acs.molpharmaceut.8b01232 ↗
4. Simon AT, Dutta D, Chattopadhyay A, Ghosh SS (2021) Quercetin-loaded luminescent hydroxyapatite nanoparticles for theranostic application in monolayer and spheroid cultures of cervical cancer cell line in vitro. ACS Appl Bio Mater 4:4495–4506. https://doi.org/10.1021/acsabm.1c0025510.1021/acsabm.1c00255 ↗
5. Lu S, Lei X, Ren H, Zheng S, Qiang J, Zhang Z, Chen Y, Wei T, Wang F, Chen X (2020) PEGylated dimeric BODIPY photosensitizers as nanocarriers for combined chemotherapy and cathepsin B-activated photodynamic therapy in 3D tumor spheroids. ACS Appl Bio Mater 3:3835–3845. https://doi.org/10.1021/acsabm.0c0039410.1021/acsabm.0c00394 ↗
6. Fung MKL, Chan GC-F (2017) Drug-induced amino acid deprivation as strategy for cancer therapy. J Hematol Oncol 10:144. https://doi.org/10.1186/s13045-017-0509-910.1186/s13045-017-0509-9 ↗
7. Butler M, van der Meer LT, van Leeuwen FN (2021) Amino acid depletion therapies: starving cancer cells to death. Trends Endocrinol Metab 32:367–381. https://doi.org/10.1016/j.tem.2021.03.00310.1016/j.tem.2021.03.003 ↗
8. Métayer LE, Brown RD, Carlebur S, Burke GAA, Brown GC (2019) Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts. Apoptosis 24:145–156. https://doi.org/10.1007/s10495-018-1506-310.1007/s10495-018-1506-3 ↗
9. Li L, Mao Y, Zhao L, Li L, Wu J, Zhao M, Du W, Yu L, Jiang P (2019) p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis. Nature 567:253–256. https://doi.org/10.1038/s41586-019-0996-710.1038/s41586-019-0996-7 ↗
10. Kumari N, Bansal S (2021) Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment. Cancer Chemother Pharmacol 88:565–594. https://doi.org/10.1007/s00280-021-04335-w10.1007/s00280-021-04335-w ↗
11. Loayza-Puch F, Rooijers K, Buil LCM, Zijlstra J, Oude Vrielink JF, Lopes R, Ugalde AP, van Breugel P, Hofland I, Wesseling J, van Tellingen O, Bex A, Agami R (2016) Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature 530:490–494. https://doi.org/10.1038/nature1698210.1038/nature16982 ↗
12. Knott SRV, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, Turgeon MO, Fish L, Erard N, Gable AL, Maceli AR, Dickopf S, Papachristou EK, D’Santos CS, Carey LA, Wilkinson JE, Harrell JC, Perou CM, Goodarzi H, Poulogiannis G, Hannon GJ (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378–381. https://doi.org/10.1038/nature2546510.1038/nature25465 ↗
13. Richards NGJ, Kilberg MS (2006) Asparagine synthetase chemotherapy. Annu Rev Biochem 75:629–654. https://doi.org/10.1146/annurev.biochem.75.103004.14252010.1146/annurev.biochem.75.103004.142520 ↗
14. Bueno CZ, Apolinário AC, Duro-Castano A, Poma A, Pessoa A Jr, Rangel-Yagui CO, Battaglia G (2020) l-Asparaginase encapsulation into asymmetric permeable polymersomes. ACS Macro Lett 9:1471–1477. https://doi.org/10.1021/acsmacrolett.0c0061910.1021/acsmacrolett.0c00619 ↗
15. Brito AEM, Pessoa A Jr, Converti A, Rangel-Yagui CO, da Silva JAD, Apolinário AC (2019) Poly (lactic-co-glycolic acid) nanospheres allow for high l-asparaginase encapsulation yield and activity. Mater Sci Eng C Mater Biol Appl 98:524–534. https://doi.org/10.1016/j.msec.2019.01.00310.1016/j.msec.2019.01.003 ↗
16. Ha W, Meng X-W, Li Q, Fan MM, Peng SL, Ding LS, Tian X, Zhang S, Li BJ (2010) Self-assembly hollow nanosphere for enzyme encapsulation. Soft Matt 6:1405–1408. https://doi.org/10.1039/B925747K10.1039/B925747K ↗
17. Al-Dulimi AG, Al-Saffar AZ, Sulaiman GM, Khalil KAA, Khashan KS, Al-Shmgani HSA, Ahmed EM (2020) Immobilization of l-asparaginase on gold nanoparticles for novel drug Delivery approach as anti-cancer agent against human breast carcinoma cells. J Mater Res Technol 9:15394–15411. https://doi.org/10.1016/j.jmrt.2020.10.02110.1016/j.jmrt.2020.10.021 ↗
18. Ortac I, Simberg D, Yeh Y, Yang J, Messmer B, Trogler WC, Tsien RY, Esener S (2014) Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes. Nano Lett 14:3023–3032. https://doi.org/10.1021/nl404360k10.1021/nl404360k ↗
19. Murayama S, Su B, Okabe K, Kishimur A, Osada K, Miura M, Funatsu T, Kataoka K, Kato M (2012) NanoPARCEL: a method for controlling cellular behavior with external light. Chem Commun (Camb) 48:8380–8382. https://doi.org/10.1039/C2CC32718J10.1039/C2CC32718J ↗
20. Murayama S, Kos P, Miyata K, Kataoka K, Wagner E, Kato M (2014) Gene regulation by intracellular Delivery and photodegradation of nanoparticles containing small interfering RNA. Macromol Biosci 14:626–631. https://doi.org/10.1002/mabi.20130039310.1002/mabi.201300393 ↗
21. Murayama S, Sasaki R, Sakaguchi S, Takaki T, Kato M (2023) Stabilizing and prolonging the antioxidant activity of catalase using nondegradable nanoparticles. Sens Mater 35:3525–3535. https://doi.org/10.18494/SAM455710.18494/SAM4557 ↗
22. Furusawa A, Miyamoto M, Takano M, Tsuda H, Song Y, Aoki D, Miyasaka N, Inazawa J, Inoue J (2018) Ovarian cancer therapeutic potential of glutamine depletion based on GS expression. Carcinogenesis 39:758–766. https://doi.org/10.1093/carcin/bgy03310.1093/carcin/bgy033 ↗
23. Murayama S, Ishizuka F, Takagi K, Inoda H, Sano A, Santa T, Kato M (2012) Small mesh size hydrogel for functional photocontrol of encapsulated enzymes and small probe molecules. Anal Chem 84:1374–1379. https://doi.org/10.1021/ac202360310.1021/ac2023603 ↗
24. Kunishima M, Kawachi C, Monta J, Terao K, Iwasaki F, Tani S (1999) 4-(4,6-Dimethoxy-1,3,5-Triazin-2-yl)-4-methyl-Morpholinium chloride: an efficient condensing agent leading to the formation of amides and esters. Tetrahedron 55:13159–13170. https://doi.org/10.1016/S0040-4020(99)00809-110.1016/S0040-4020(99)00809-1 ↗